Scheepers LEJM, et al. - Authors evaluated non-persistence and non-adherence in patients with newly diagnosed gout. They also identified the factors related to poor medication adherence. They noted a poor medication adherence among gout patients starting allopurinol. This was noted in particular among females and younger patients and patients with fewer comorbidities. In those restarting after a first gap, low medication adherence was noted. An increase in the risk for non-persistence and non-adherence was seen in the females and current smokers, where a decrease in the risk was noted in older age, overweight, receiving anti-hypertensive medication or colchicine and suffering from dementia, diabetes or dyslipidaemia.